Name: SKIN Income Statement - Skinhealth Systems Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

SKIN - Skinhealth Systems Inc.

USD | NASDAQ | Healthcare

SKIN Income Statement - Skinhealth Systems Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20
Revenues
Revenues	64.9	82.4	70.7	78.2	69.6	83.5	78.8	90.6	81.4	96.8	97.4	117.5	86.3	98.1	88.8	103.5

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD, except per-share data)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Revenues
Revenues	296.1	300.8	334.3	398.0	365.9	260.1	119.1	166.6
Cost of Revenue	103.9	104.4	152.0	242.9	117.1	81.5	51.9	60.1
Gross Profit	192.2	196.4	182.3	155.1	248.8	178.5	67.2	106.5
Operating Expenses
Research & Development	5.7	5.6	6.3	10.1	8.4	8.2	3.4	4.6
Selling General & Administrative	-	-	-	-	-
Operating Income
Operating Income	(10.6)	(20.8)	(67.8)	(130.9)	(25.8)	(39.9)	(17.2)	13.5
Non-Operating
Interest Income	7.4	9.0	16.6	23.2	9.2	0.0	0.0	-
Interest Expense	23.2	19.3	10.4	13.6	13.4	11.8
Tax & Net
Income Tax Expense	2.5	3.6	(0.5)	(1.8)	1.1	(1.9)	(9.3)	(1.3)
Net Income From Continuing Ops	(6.1)	(9.5)	(29.1)	(100.1)	44.2
Per Share
EPS Basic	(0.05)	(0.08)	(0.23)	(0.76)	0.30	(3.71)	(0.85)	(0.05)
EPS Diluted	(0.05)	(0.16)	(0.36)	(0.76)	(0.23)	(3.71)
Supplementary Data
EBITDA	-	(17.0)	(57.8)	(119.6)	(18.7)	(35.4)	(14.6)	14.8
EBIT	(10.6)	(20.8)	(67.8)	(130.9)	(25.8)	(39.9)

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Operating Expenses
Research & Development	1.1	1.7	1.7	1.3	1.0	1.2	1.1	1.2	2.8	3.0	1.8	2.9	2.3	1.4	2.2	2.6	2.2	1.9	1.9	3.0	1.5	-	0.6	0.6	-
Selling General & Administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Selling & Marketing	23.2	23.5	20.9	23.1	26.0	26.5	27.6	30.5	33.7	32.0	30.7	43.0	38.7	39.0	39.8	44.9	36.4
General & Administrative	21.9	27.7	29.3	27.5	33.6	31.8	33.4	31.4	28.9	29.0	37.0	35.1	30.4	28.5	23.8	27.6	26.3
Depreciation & Amortization	0.6	-	-	-	1.9	-	-	-	2.8	-	-	-	1.8	1.9	2.0	1.9
Amortization of Intangibles	3.6	-	-	-	3.2	-	-	-	5.0	-	-	-	3.9	-	-	-	3.6
Other Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Operating Expenses	46.2	52.9	51.9	51.8	60.6	59.5	62.2	63.1	65.4	64.0	69.5	81.0	71.4	68.9	65.7	75.1

Operating Income
Operating Income	(1.8)	0.2	(6.2)	(2.7)	(12.0)	(7.2)	(21.5)	(22.1)	(17.0)	(18.4)	(82.1)	(13.1)	(17.3)	(2.4)	(4.4)	(5.0)	(14.0)	(10.5)	(5.5)	(26.4)	2.4	-	2.8	(7.9)	-

Tax & Net
Income Tax Expense	(0.2)	3.3	0.4	(1.0)	0.9	(1.4)	1.9	(0.4)	(0.7)	0.6	3.5	(2.2)	(3.7)	(0.8)	(0.8)	0.1	2.6	1.4	(1.1)	(1.9)	(0.3)	-	(0.6)	(3.1)	-
Net Income From Continuing Ops	(6.6)	(8.1)	(11.0)	19.7	(10.1)	(10.3)	(18.3)	0.2	(0.7)	(9.4)	(73.8)	3.4	(20.3)	6.5	(0.1)	6.3	31.5
Net Income From Discontinued Ops	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	(6.6)	(8.1)	(11.0)	19.7	(10.1)	(10.3)	(18.3)	0.2	(0.7)	(9.4)	(73.8)	3.4	(20.3)	6.5	(0.1)	6.3	31.5
Net Income Attributable To Parent	(6.6)	(8.1)	(11.0)	19.7	(10.1)	(10.3)	(18.3)	0.2	(0.7)	(9.4)	(73.8)	3.4	(20.3)	6.5	(0.1)	6.3
Less: Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Less: Preferred Dividends	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income To Common Shareholders	(6.6)	(8.1)	(11.0)	19.7	(10.1)	(10.3)	(18.3)	0.2	(0.7)	(9.4)	(73.8)	3.4	(20.3)	6.5	(0.1)

Per Share
EPS Basic	(0.05)	-	(0.09)	0.16	(0.08)	-	(0.15)	0.00	(0.01)	-	(0.56)	0.03	(0.15)	-	0.00	0.04	0.21	-	(1.63)	(1.52)	(0.09)	-	(0.06)	(0.30)	-
EPS Diluted	(0.05)	-	(0.09)	0.03	(0.08)	-	(0.15)	(0.10)	(0.10)	-	(0.56)	0.03	(0.15)	-	(0.03)	(0.06)	(0.13)	-
Shares Basic	127.8	-	126.9	126.1	125.1	-	124.1	123.7	123.1	-	132.9	132.7	132.4	-	150.8	150.7	150.6	-
Shares Diluted	131.4	-	126.9	140.3	125.1	-	124.1	141.9	144.5	-	132.9	132.7	132.4	-	151.4	151.7	152.7	-

Supplementary Data
EBITDA	(1.2)	-	-	-	(10.2)	-	-	-	(14.2)	-	-	-	(15.5)	(0.6)	(2.4)	(3.2)	(12.6)	(8.5)	(4.4)	(25.6)	3.1	-	3.5	(7.3)	-
EBIT	(1.8)	0.2	(6.2)	(2.7)	(12.0)	(7.2)	(21.5)	(22.1)	(17.0)	(18.4)	(82.1)	(13.1)	(17.3)	(2.4)	(4.4)	(5.0)	(14.0)	(10.5)	(5.5)

Non-Operating
Interest Income	1.5	1.5	1.3	3.2	3.0	2.2	4.9	4.2	5.4	6.4	6.8	5.7	4.3	5.6	2.9	0.7	(0.0)	-	-	-	-	-	-	-	-
Interest Expense	6.3	6.4	6.3	4.1	2.5	2.5	2.5	2.5	3.0	3.4	3.4	3.4	3.4	3.4	3.4	3.2	3.4	-
Income From Equity Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Operating Income	1.0	0.1	0.6	18.1	0.1	0.1	0.1	17.3	16.1	(0.1)	4.9	0.0	0.4	(64.6)	3.5	11.4	48.1
Pre-Tax Income	(6.8)	(4.8)	(10.6)	18.7	(9.2)	(11.7)	(16.3)	(0.2)	(1.3)	(8.8)	(70.3)	1.2	(23.9)	5.8	(0.9)	6.4